These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 10936889)

  • 41. A survival-stratification model of human colorectal carcinomas with beta-catenin and p27kip1.
    Cheah PY; Choo PH; Yao J; Eu KW; Seow-Choen F
    Cancer; 2002 Dec; 95(12):2479-86. PubMed ID: 12467060
    [TBL] [Abstract][Full Text] [Related]  

  • 42. p27(kip1) expression in rectal cancer correlates with disease-free survival.
    Günther K; Jung A; Völker U; Meyer M; Brabletz T; Matzel KE; Reymond MA; Kirchner T; Hohenberger W
    J Surg Res; 2000 Jul; 92(1):78-84. PubMed ID: 10864486
    [TBL] [Abstract][Full Text] [Related]  

  • 43. p27(Kip1) expression in normal epithelia, precancerous lesions, and carcinomas of the gallbladder: association with cancer progression and prognosis.
    Hui AM; Li X; Shi YZ; Torzilli G; Takayama T; Makuuchi M
    Hepatology; 2000 May; 31(5):1068-72. PubMed ID: 10796881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Osteoclast differentiation is associated with transient upregulation of cyclin-dependent kinase inhibitors p21(WAF1/CIP1) and p27(KIP1).
    Okahashi N; Murase Y; Koseki T; Sato T; Yamato K; Nishihara T
    J Cell Biochem; 2001; 80(3):339-45. PubMed ID: 11135363
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subcellular localization of p27kip1 expression predicts poor prognosis in human ovarian cancer.
    Rosen DG; Yang G; Cai KQ; Bast RC; Gershenson DM; Silva EG; Liu J
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):632-7. PubMed ID: 15701850
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival.
    Del Pizzo JJ; Borkowski A; Jacobs SC; Kyprianou N
    Am J Pathol; 1999 Oct; 155(4):1129-36. PubMed ID: 10514396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma.
    Resnick MB; Schacter P; Finkelstein Y; Kellner Y; Cohen O
    Mod Pathol; 1998 Aug; 11(8):735-9. PubMed ID: 9720501
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic significance of p27 expression in carcinoma of the oral cavity and oropharynx.
    Venkatesan TK; Kuropkat C; Caldarelli DD; Panje WR; Hutchinson JC; Chen S; Coon JS
    Laryngoscope; 1999 Aug; 109(8):1329-33. PubMed ID: 10443844
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploitation of a non-apoptotic caspase to regulate the abundance of the cdkI p27(KIP1) in transformed lymphoid cells.
    Frost V; Al-Mehairi S; Sinclair AJ
    Oncogene; 2001 May; 20(22):2737-48. PubMed ID: 11420686
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression patterns of p27Kip1 and Ki-67 in cholesteatoma epithelium.
    Chae SW; Song JJ; Suh HK; Jung HH; Lim HH; Hwang SJ
    Laryngoscope; 2000 Nov; 110(11):1898-901. PubMed ID: 11081606
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of c-myc regulation in Zta-mediated induction of the cyclin-dependent kinase inhibitors p21 and p27 and cell growth arrest.
    Rodriguez A; Jung EJ; Yin Q; Cayrol C; Flemington EK
    Virology; 2001 Jun; 284(2):159-69. PubMed ID: 11384216
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1).
    Kouvaraki MA; Rassidakis GZ; Tian L; Kumar R; Kittas C; Claret FX
    Cancer Res; 2003 Jun; 63(11):2977-81. PubMed ID: 12782606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Kip1 meets SKP2: new links in cell-cycle control.
    Amati B; Vlach J
    Nat Cell Biol; 1999 Aug; 1(4):E91-3. PubMed ID: 10559929
    [No Abstract]   [Full Text] [Related]  

  • 54. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.
    Motti ML; Califano D; Baldassarre G; Celetti A; Merolla F; Forzati F; Napolitano M; Tavernise B; Fusco A; Viglietto G
    Carcinogenesis; 2005 Jun; 26(6):1021-34. PubMed ID: 15718252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. pRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: their clinical significance.
    Claudio PP; Russo G; Kumar CA; Minimo C; Farina A; Tutton S; Nuzzo G; Giuliante F; Angeloni G; Maria V; Vecchio FM; Campli CD; Giordano A
    Clin Cancer Res; 2004 May; 10(10):3509-17. PubMed ID: 15161709
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cdk pathway: cyclin-dependent kinases and cyclin-dependent kinase inhibitors.
    Gitig DM; Koff A
    Methods Mol Biol; 2000; 142():109-23. PubMed ID: 10806617
    [No Abstract]   [Full Text] [Related]  

  • 57. Regulation of the cdk inhibitor p27 and its deregulation in cancer.
    Slingerland J; Pagano M
    J Cell Physiol; 2000 Apr; 183(1):10-7. PubMed ID: 10699961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. p27: a pleiotropic regulator of cellular phenotype and a target for cell cycle dysregulation in cancer.
    Desdouets C; Bréchot C
    Pathol Biol (Paris); 2000 Apr; 48(3):203-10. PubMed ID: 10858954
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic role of p27Kip1 and apoptosis in human breast cancer.
    Wu J; Shen ZZ; Lu JS; Jiang M; Han QX; Fontana JA; Barsky SH; Shao ZM
    Br J Cancer; 1999 Mar; 79(9-10):1572-8. PubMed ID: 10188908
    [TBL] [Abstract][Full Text] [Related]  

  • 60. p27 expression correlates with prognosis in patients with hypopharyngeal cancer.
    Mineta H; Miura K; Suzuki I; Takebayashi S; Misawa K; Ueda Y; Ichimura K
    Anticancer Res; 1999; 19(5C):4407-12. PubMed ID: 10650784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.